Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study.

Peter R MillarBrian A GordonPatrick H LuckettTammie L S BenzingerCarlos CruchagaAnne M FaganJason J HassenstabRichard J PerrinSuzanne E SchindlerRicardo F AllegriGregory S DayMartin R FarlowHiroshi MoriGeorg Nüblingnull nullRandall J BatemanJohn C MorrisBeau M Ances

Published in: eLife (2023)

This work was supported by the National Institutes of Health (P01-AG026276, P01- AG03991, P30-AG066444, 5-R01-AG052550, 5-R01-AG057680, 1-R01-AG067505, 1S10RR022984-01A1, and U19-AG032438), the BrightFocus Foundation (A2022014F), and the Alzheimer's Association (SG-20-690363-DIAN).

Keyphrases

quantum dots
highly efficient
visible light
healthcare
mild cognitive impairment
cognitive decline
quality improvement
risk assessment
chronic pain
pain management
human health
subarachnoid hemorrhage